Key result
GIP regulates K(V)1.4 cell surface expression and modulates A-type potassium currents via PKA-dependent phosphorylation, which is critical for its insulinotropic action.
GIP regulates K(V)1.4 cell surface expression and modulates A-type potassium currents, which is important for its insulinotropic action in pancreatic beta-cells.
May guide GIP-based diabetes therapies; animal data leave mechanism's human relevance open.
The mechanisms involved in glucose regulation of insulin secretion by ATP-sensitive (K(ATP)) and calcium-activated (K(CA)) potassium channels have been extensively studied, but less is known about the role of voltage-gated (K(V)) potassium channels in pancreatic beta-cells. The incretin hormone, glucose-dependent insulinotropic polypeptide (GIP) stimulates insulin secretion by potentiating events underlying membrane depolarization and exerting direct effects on exocytosis. In the present study, we identified a novel role for GIP in regulating K(V)1.4 channel endocytosis. In GIP receptor-expressing HEK293 cells, GIP reduced A-type peak ionic current amplitude of K(V)1.4 via activation of protein kinase A (PKA). Using mutant forms of K(V)1.4 with Ala-Ser/Thr substitutions in a potential PKA phosphorylation site, C-terminal phosphorylation was shown to be linked to GIP-mediated current amplitude decreases. Proteinase K digestion and immunocytochemical studies on mutant K(V)1.4 localization following GIP stimulation demonstrated phosphorylation-dependent rapid endocytosis of K(V)1.4. Expression of K(V)1.4 protein was also demonstrated in human beta-cells; GIP treatment resulting in similar decreases in A-type potassium current peak amplitude to those in HEK293 cells. Transient overexpression in INS-1 beta-cells (clone 832/13) of wild-type (WT) K(V)1.4, or a T601A mutant form resistant to PKA phosphorylation, resulted in reduced glucose-stimulated insulin secretion; WT K(V)1.4 overexpression potentiated GIP-induced insulin secretion, whereas this response was absent in T601A cells. These results strongly support an important novel role for GIP in regulating K(V)1.4 cell surface expression and modulation of A-type potassium currents, which is likely to be critically important for its insulinotropic action.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2005) studied this question. Glucose-dependent insulinotropic polypeptide (GIP) was evaluated on K(V)1.4 channel endocytosis and A-type potassium current peak amplitude. GIP regulates K(V)1.4 cell surface expression and modulates A-type potassium currents via PKA-dependent phosphorylation, which is critical for its insulinotropic action.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: